Initial Trials of Anti-CD80 Monoclonal Antibody (Galiximab) Therapy for Patients with Relapsed or Refractory Follicular Lymphoma - Concepedia

Concepedia

Publication | Closed Access

Initial Trials of Anti-CD80 Monoclonal Antibody (Galiximab) Therapy for Patients with Relapsed or Refractory Follicular Lymphoma

35

Citations

7

References

2003

Year

Anas Younes, Kandasamy Hariharan, R. S. Allen, Bryan R. Leigh

Clinical Lymphoma

Anti-cd80 Monoclonal AntibodyLymphoid NeoplasiaInitial TrialsMedicineMalignant Blood DisorderImmunologyRefractory Follicular LymphomaImmunotherapyOncologyRadiation Oncology

References

	Year	Citations

Page 1